Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors.

Autor: Kropp KN; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Fatho M; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Huduti E; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Faust M; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Lübcke S; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Lennerz V; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Paschen A; Dermatology, University Hospital, University Duisburg/Essen and German Cancer Research Consortium (DKTK), Partner Site Essen/Duesseldorf, Essen, Germany., Theobald M; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Wölfel T; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany., Wölfel C; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Mainz, Germany.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Oct 02; Vol. 14, pp. 1245559. Date of Electronic Publication: 2023 Oct 02 (Print Publication: 2023).

Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Autor: Chen, Xinyi¹ (AUTHOR) joanna.m.troka@kcl.ac.uk, Habib, Shabana¹ (AUTHOR) avigail.rahimi@kcl.ac.uk, Alexandru, Madalina¹ (AUTHOR) heather.bax@kcl.ac.uk, Chauhan, Jitesh¹ (AUTHOR), Evan, Theodore¹ (AUTHOR), Troka, Joanna M.¹ (AUTHOR), Rahimi, Avigail¹ (AUTHOR), Esapa, Benjamina¹ (AUTHOR), Tull, Thomas J.¹ (AUTHOR), Ng, Wen Zhe¹ (AUTHOR), Fitzpatrick, Amanda^1,2,3 (AUTHOR), Wu, Yin^1,3,4 (AUTHOR), Geh, Jenny L. C.^5,6 (AUTHOR), Lloyd-Hughes, Hawys⁶ (AUTHOR), Palhares, Lais C. G. F.¹ (AUTHOR), Adams, Rebecca¹ (AUTHOR), Bax, Heather J.¹ (AUTHOR), Whittaker, Sean¹ (AUTHOR), Jacków-Malinowska, Joanna¹ (AUTHOR), Karagiannis, Sophia N.^1,3 (AUTHOR) sophia.karagiannis@kcl.ac.uk

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3260. 22p.

Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies.

Autor: Limonta, Patrizia¹ (AUTHOR) patrizia.limonta@unimi.it, Chiaramonte, Raffaella² (AUTHOR) raffaella.chiaramonte@unimi.it, Casati, Lavinia² (AUTHOR) patrizia.limonta@unimi.it

Publikováno v: Cancers. Aug2024, Vol. 16 Issue 16, p2861. 36p.

Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.

Autor: Chen, Min¹ (AUTHOR) mchenst@outlook.com, Zhang, Xin² (AUTHOR), Ming, Zihe³ (AUTHOR), Lingyu⁴ (AUTHOR), Feng, Xiaorong⁵ (AUTHOR), Han, Zhenguo⁶ (AUTHOR), An, Han-Xiang^1,7 (AUTHOR) anhanxiang@hotmail.com

Publikováno v: Journal of Translational Medicine. 3/27/2024, Vol. 22 Issue 1, p1-15. 15p.

Interconversion of Cancer Cells and Induced Pluripotent Stem Cells.

Autor: Sarker, Drishty B.¹ (AUTHOR) ds22@fsu.edu, Xue, Yu¹ (AUTHOR) yx21@fsu.edu, Mahmud, Faiza¹ (AUTHOR) fm23@fsu.edu, Jocelyn, Jonathan A.¹ (AUTHOR) jaj21g@fsu.edu, Sang, Qing-Xiang Amy^1,2 (AUTHOR) qxsang@chem.fsu.edu

Publikováno v: Cells (2073-4409). Jan2024, Vol. 13 Issue 2, p125. 22p.